Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00444145 · ClinicalTrials.gov registry record · Phase 4
Do Laryngeal Tissue Changes in Patients Suspected of Having Laryngopharyngeal Reflux Predict Response to Treatment?
A Phase 4 study, sponsored by Vanderbilt University Medical Center.
- Completed
- Registry status
- Phase 4
- Development phase
- 38
- Enrollment target
NCT00444145 is a Phase 4 study that has completed, run by Vanderbilt University Medical Center. The registered enrollment target is 38 participants.
The verdict
NCT00444145, a Phase 4 study, has completed, sponsored by Vanderbilt University Medical Center.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 38 participants
- Enrollment target
Study Summary
The purpose of the study is to determine if tissue changes are predictor of clinical response to therapy. The hypothesis is that the patients who have laryngeal signs and symptoms related to acid reflux, will have ultrastructural changes on a laryngeal biopsy which are predictors of response to therapy.
Interventions
- DRUG Prevacid
- PROCEDURE Esophageal and Laryngeal Biopsies
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 38 participants |
| Start Date | 2007-03 |
| Est. Completion | 2009-12 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00444145
The ClinicalTrials.gov registry entry for NCT00444145 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 38 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Vanderbilt University Medical Center, which has 677 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Prevacid is the first listed.
NCT00444145 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00444145 about?
NCT00444145 is a clinical study titled "Do Laryngeal Tissue Changes in Patients Suspected of Having Laryngopharyngeal Reflux Predict Response to Treatment?". The purpose of the study is to determine if tissue changes are predictor of clinical response to therapy. The hypothesis is that the patients who have laryngeal signs and symptoms related to acid reflux, will have ultrastructural changes on a laryngeal biopsy which are predictors of response to the...
What is the current status of trial NCT00444145?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 38 participants. The study started on 2007-03. Estimated completion is 2009-12.
What interventions are being tested in trial NCT00444145?
The interventions under investigation include: Prevacid (DRUG), Esophageal and Laryngeal Biopsies (PROCEDURE).
Who is sponsoring clinical trial NCT00444145?
This trial is sponsored by Vanderbilt University Medical Center, which has 677 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.